132 related articles for article (PubMed ID: 2862957)
21. Dynorphin A (1-13) neurotoxicity in vitro: opioid and non-opioid mechanisms in mouse spinal cord neurons.
Hauser KF; Foldes JK; Turbek CS
Exp Neurol; 1999 Dec; 160(2):361-75. PubMed ID: 10619553
[TBL] [Abstract][Full Text] [Related]
22. Ovarian sex steroid-dependent plasticity of nociceptin/orphanin FQ and opioid modulation of spinal dynorphin release.
Gupta DS; Kelson AB; Polgar WE; Toll L; Szücs M; Gintzler AR
J Pharmacol Exp Ther; 2001 Sep; 298(3):1213-20. PubMed ID: 11504823
[TBL] [Abstract][Full Text] [Related]
23. Effects of selective and non-selective kappa-opioid receptor agonists on cutaneous C-fibre-evoked responses of rat dorsal horn neurones.
Knox RJ; Dickenson AH
Brain Res; 1987 Jul; 415(1):21-9. PubMed ID: 2887243
[TBL] [Abstract][Full Text] [Related]
24. Stimulation by corticotropin-releasing factor of the release of immunoreactive dynorphin A from mouse spinal cords in vitro.
Song ZH; Takemori AE
Eur J Pharmacol; 1992 Nov; 222(1):27-32. PubMed ID: 1361439
[TBL] [Abstract][Full Text] [Related]
25. [Dynorphin: analgesic effect via kappa receptors in spinal cord of the spinal cords of rats].
Xie GX; Han JS
Zhongguo Yao Li Xue Bao; 1984 Dec; 5(4):231-4. PubMed ID: 6152645
[No Abstract] [Full Text] [Related]
26. Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: stimulus specificity, behavioral parameters and opioid receptor binding.
Iadarola MJ; Brady LS; Draisci G; Dubner R
Pain; 1988 Dec; 35(3):313-326. PubMed ID: 2906426
[TBL] [Abstract][Full Text] [Related]
27. Effects of synchronous or asynchronous electroacupuncture stimulation with low versus high frequency on spinal opioid release and tail flick nociception.
Wang Y; Zhang Y; Wang W; Cao Y; Han JS
Exp Neurol; 2005 Mar; 192(1):156-62. PubMed ID: 15698629
[TBL] [Abstract][Full Text] [Related]
28. Dynorphin-(1-8) inhibits the release of substance P-like immunoreactivity in the spinal cord of rats following a noxious mechanical stimulus.
Zachariou V; Goldstein BD
Eur J Pharmacol; 1997 Apr; 323(2-3):159-65. PubMed ID: 9128834
[TBL] [Abstract][Full Text] [Related]
29. Contribution of spinal mu(1)-opioid receptors and dynorphin B to the antinociception induced by Tyr-d-Arg-Phe-Sar.
Mizoguchi H; Ito K; Watanabe H; Watanabe C; Katsuyama S; Fujimura T; Sakurada T; Sakurada S
Peptides; 2006 Nov; 27(11):2786-93. PubMed ID: 16919848
[TBL] [Abstract][Full Text] [Related]
30. Receptor preference of dynorphin A fragments in the mouse vas deferens determined by different techniques.
Schulz R; Wüster M; Herz A
J Pharmacol Exp Ther; 1984 Jul; 230(1):200-4. PubMed ID: 6146706
[TBL] [Abstract][Full Text] [Related]
31. [MK-801 suppresses dynorphin A (1-17)-induced facilitation of nociceptive responses to formalin in rats].
Qi WX; Lu CR
Sheng Li Xue Bao; 2003 Feb; 55(1):101-4. PubMed ID: 12598944
[TBL] [Abstract][Full Text] [Related]
32. Increased release of immunoreactive dynorphin A1-17 from the spinal cord after intrathecal treatment with endomorphin-2 in anesthetized rats.
Leitermann RJ; Terashvili M; Mizoguchi H; Wu HE; Chen F; Clithero A; Tseng LF
Eur J Pharmacol; 2004 Nov; 504(3):177-83. PubMed ID: 15541419
[TBL] [Abstract][Full Text] [Related]
33. Spinal blockade of opioid receptors prevents the analgesia produced by TENS in arthritic rats.
Sluka KA; Deacon M; Stibal A; Strissel S; Terpstra A
J Pharmacol Exp Ther; 1999 May; 289(2):840-6. PubMed ID: 10215661
[TBL] [Abstract][Full Text] [Related]
34. Absence of spinal response to extracorporeal shock waves on the endogenous opioid systems in the rat.
Haake M; Thon A; Bette M
Ultrasound Med Biol; 2001 Feb; 27(2):279-84. PubMed ID: 11316537
[TBL] [Abstract][Full Text] [Related]
35. Bullatine A stimulates spinal microglial dynorphin A expression to produce anti-hypersensitivity in a variety of rat pain models.
Huang Q; Mao XF; Wu HY; Li TF; Sun ML; Liu H; Wang YX
J Neuroinflammation; 2016 Aug; 13(1):214. PubMed ID: 27577933
[TBL] [Abstract][Full Text] [Related]
36. Endogenous opioid immunoreactivity in rat spinal cord following traumatic injury.
Faden AI; Molineaux CJ; Rosenberger JG; Jacobs TP; Cox BM
Ann Neurol; 1985 Apr; 17(4):386-90. PubMed ID: 2860844
[TBL] [Abstract][Full Text] [Related]
37. Intrathecal morphine-3-glucuronide-induced nociceptive behavior via Delta-2 opioid receptors in the spinal cord.
Komatsu T; Katsuyama S; Nagase H; Mizoguchi H; Sakurada C; Tsuzuki M; Sakurada S; Sakurada T
Pharmacol Biochem Behav; 2016 Jan; 140():68-74. PubMed ID: 26476133
[TBL] [Abstract][Full Text] [Related]
38. Aconitum-Derived Bulleyaconitine A Exhibits Antihypersensitivity Through Direct Stimulating Dynorphin A Expression in Spinal Microglia.
Li TF; Fan H; Wang YX
J Pain; 2016 May; 17(5):530-48. PubMed ID: 26762790
[TBL] [Abstract][Full Text] [Related]
39. N-methyl-D-aspartate (NMDA) and opioid receptors mediate dynorphin-induced spinal cord injury: behavioral and histological studies.
Bakshi R; Ni RX; Faden AI
Brain Res; 1992 May; 580(1-2):255-64. PubMed ID: 1380394
[TBL] [Abstract][Full Text] [Related]
40. Nonopioidergic mechanism mediating morphine-induced antianalgesia in the mouse spinal cord.
Wu HE; Thompson J; Sun HS; Leitermann RJ; Fujimoto JM; Tseng LF
J Pharmacol Exp Ther; 2004 Jul; 310(1):240-6. PubMed ID: 14999057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
